Life Tech Mass Spec Revenues Rise 2 Percent in Q3; Firm Prepares to Transfer Arm to Danaher

Life Tech reported mass spec revenues of $111 million for the quarter, the last full quarter that that business will remain with the company. Regulatory approval for the deal is expected "shortly," and Danaher's acquisition of the mass spec business is expected to close possibly before the end of next month.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.